Note 20 - Fair Value Disclosures - Fair Value of Financial Instruments (Details) - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Reported Value Measurement [Member]
Cash and cash equivalents	$ 1,908	$ 3,757
Other receivables	113,999	424,110
Note receivable - related party	44,859	44,859
Loans payable	527,379	10,121,411
Loans payable – related parties	1,363,354	1,362,600
Patent acquisition liability	1,380,000	720,000
Convertible notes payable	6,730,448	6,224,325
Convertible notes payable – related parties	2,558,681	2,558,681
Reported Value Measurement [Member] \| Emergence Global [Member]
Advances to Subsidiary	17,901
Reported Value Measurement [Member] \| CEN Biotech Ukraine [Member]
Advances to Subsidiary	1,179,328	1,065,328
Estimate of Fair Value Measurement [Member]
Cash and cash equivalents	1,908	3,757
Other receivables	113,999	424,110
Note receivable - related party	44,859	44,859
Loans payable	527,379	10,121,411
Loans payable – related parties
Patent acquisition liability	1,380,000	720,000
Convertible notes payable	7,766,663	6,918,486
Convertible notes payable – related parties
Estimate of Fair Value Measurement [Member] \| Emergence Global [Member]
Advances to Subsidiary	17,901
Estimate of Fair Value Measurement [Member] \| CEN Biotech Ukraine [Member]
Advances to Subsidiary	1,179,328	1,065,328
Estimate of Fair Value Measurement [Member] \| Fair Value, Inputs, Level 1 [Member]
Cash and cash equivalents
Other receivables
Note receivable - related party
Loans payable
Loans payable – related parties
Patent acquisition liability
Convertible notes payable
Convertible notes payable – related parties
Estimate of Fair Value Measurement [Member] \| Fair Value, Inputs, Level 1 [Member] \| Emergence Global [Member]
Advances to Subsidiary
Estimate of Fair Value Measurement [Member] \| Fair Value, Inputs, Level 1 [Member] \| CEN Biotech Ukraine [Member]
Advances to Subsidiary
Estimate of Fair Value Measurement [Member] \| Fair Value, Inputs, Level 2 [Member]
Cash and cash equivalents	1,908	3,757
Other receivables
Note receivable - related party
Loans payable
Loans payable – related parties
Patent acquisition liability
Convertible notes payable
Convertible notes payable – related parties
Estimate of Fair Value Measurement [Member] \| Fair Value, Inputs, Level 2 [Member] \| Emergence Global [Member]
Advances to Subsidiary
Estimate of Fair Value Measurement [Member] \| Fair Value, Inputs, Level 2 [Member] \| CEN Biotech Ukraine [Member]
Advances to Subsidiary
Estimate of Fair Value Measurement [Member] \| Fair Value, Inputs, Level 3 [Member]
Cash and cash equivalents
Other receivables	113,999	424,110
Note receivable - related party	44,859	44,859
Loans payable	527,379	10,121,411
Loans payable – related parties
Patent acquisition liability	1,380,000	720,000
Convertible notes payable	7,766,663	6,918,486
Convertible notes payable – related parties
Estimate of Fair Value Measurement [Member] \| Fair Value, Inputs, Level 3 [Member] \| Emergence Global [Member]
Advances to Subsidiary	17,901
Estimate of Fair Value Measurement [Member] \| Fair Value, Inputs, Level 3 [Member] \| CEN Biotech Ukraine [Member]
Advances to Subsidiary	$ 1,179,328	$ 1,065,328

Fair value portion of advances to subsidiary.

No definition available.

Name:	cenb_AdvancesToSubsidiaryFairValuedisclosure
Namespace Prefix:	cenb_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Fair value portion of convertible debt payable to related party.

+ References

No definition available.

+ Details

Name:	cenb_ConvertibleDebtRelatedPartyFairValueDisclosures
Namespace Prefix:	cenb_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Fair value portion of loans payable to related party.

+ References

No definition available.

+ Details

Name:	cenb_LoansPayableRelatedPartyFairValueDisclosure
Namespace Prefix:	cenb_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Fair value portion of notes receivable from related party.

+ References

No definition available.

+ Details

Name:	cenb_NotesReceivableRelatedPartyFairValueDisclosure
Namespace Prefix:	cenb_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The fair value amount of patent acquisition liability.

+ References

No definition available.

+ Details

Name:	cenb_PatentAcquisitionLiabilityFairValue
Namespace Prefix:	cenb_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.

+ References

No definition available.

+ Details

Name:	us-gaap_CashAndCashEquivalentsFairValueDisclosure
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.

+ References

No definition available.

+ Details

Name:	us-gaap_ConvertibleDebtFairValueDisclosures
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Fair value portion of contractual obligation to pay money on demand or on fixed or determinable dates.

+ References

No definition available.

+ Details

Name:	us-gaap_LoansPayableFairValueDisclosure
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Fair value portion of loan receivable, including, but not limited to, mortgage loans held for investment, finance receivables held for investment, policy loans on insurance contracts.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2196772

+ Details

Name:	us-gaap_LoansReceivableFairValueDisclosure
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Details

Name:	us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cenb_EmergenceGlobalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cenb_CENBiotechUkraineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: